29 June 2021 : Case report
A Severe Case of Diabetic Ketoacidosis and New-Onset Type 1 Diabetes Mellitus Associated with Anti-Glutamic Acid Decarboxylase Antibodies Following Immunotherapy with Pembrolizumab
Unusual or unexpected effect of treatment, Adverse events of drug therapy
DOI: 10.12659/AJCR.931702
Am J Case Rep 2021; 22:e931702
Related articles
Coming soon...
SARS-CoV-2/COVID-19
11 August 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
09 August 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937505
29 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937105
08 July 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.937212
In Press
11 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.937139
11 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936496
11 Aug 2022 : Case report 
Am J Case Rep In Press; DOI: 10.12659/AJCR.935207
11 Aug 2022 : Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.936840
Most Viewed Current Articles
13 Jul 2022 : Case report 
DOI :10.12659/AJCR.936441
Am J Case Rep 2022; 23:e936441
23 Feb 2022 : Case report
DOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250
06 Dec 2021 : Case report 
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
17 Feb 2022 : Case report 
DOI :10.12659/AJCR.934399
Am J Case Rep 2022; 23:e934399